Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Veracyte Inc (NASDAQ: VCYT) was $31.14 for the day, down -1.24% from the previous closing price of $31.53. In other words, the price has decreased by -$1.24 from its previous closing price. On the day, 0.7 million shares were traded. VCYT stock price reached its highest trading level at $31.31 during the session, while it also had its lowest trading level at $30.81.
Ratios:
Our analysis of VCYT’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.39 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 38.04. For the most recent quarter (mrq), Quick Ratio is recorded 4.46 and its Current Ratio is at 4.73. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on March 20, 2025, initiated with a Buy rating and assigned the stock a target price of $45.
On December 05, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $38 to $37.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $50.Wolfe Research initiated its Outperform rating on November 15, 2024, with a $50 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 07 ’25 when Leite John sold 7,411 shares for $31.66 per share. The transaction valued at 234,630 led to the insider holds 100,249 shares of the business.
JOHN LEITE bought 7,411 shares of VCYT for $240,932 on Mar 07 ’25. On Mar 04 ’25, another insider, ANN MCGUIRE, who serves as the Officer of the company, bought 1,142 shares for $33.56 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VCYT now has a Market Capitalization of 2427201024 and an Enterprise Value of 2188496128. As of this moment, Veracyte’s Price-to-Earnings (P/E) ratio for their current fiscal year is 101.60, and their Forward P/E ratio for the next fiscal year is 44.85. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.40. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.45 while its Price-to-Book (P/B) ratio in mrq is 2.06. Its current Enterprise Value per Revenue stands at 4.91 whereas that against EBITDA is 43.564.
Stock Price History:
The Beta on a monthly basis for VCYT is 2.05, which has changed by 0.6010283 over the last 52 weeks, in comparison to a change of 0.0635103 over the same period for the S&P500. Over the past 52 weeks, VCYT has reached a high of $47.32, while it has fallen to a 52-week low of $18.61. The 50-Day Moving Average of the stock is -7.96%, while the 200-Day Moving Average is calculated to be -9.56%.
Shares Statistics:
VCYT traded an average of 996.84K shares per day over the past three months and 1198550 shares per day over the past ten days. A total of 77.77M shares are outstanding, with a floating share count of 76.84M. Insiders hold about 1.42% of the company’s shares, while institutions hold 103.32% stake in the company. Shares short for VCYT as of 1743379200 were 4165854 with a Short Ratio of 4.18, compared to 1740700800 on 3388505. Therefore, it implies a Short% of Shares Outstanding of 4165854 and a Short% of Float of 5.96.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
